Method of treating rheumatoid arthritis with low dose type II collagen
US5856446A · kind A · utility
11Cited by
18References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 5, 1996 |
| Grant date | Jan 5, 1999 |
| Priority date | — |
| Expiry date | Jul 5, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for suppressing autoimmune response in an afflicted joint in a human. The method involves oral administration of between about 5 and 25 .mu.g per day of type II collagen.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.